Trials / Not Yet Recruiting
Not Yet RecruitingNCT06717360
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
A Multicenter, Randomized, Double-blinded, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R in Patients with Primary Hypercholesterolemia
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R in Patients with Primary Hypercholesterolemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AG2304T | AG2304T, QD, PO |
| DRUG | AG2304R | AG2304R, QD, PO |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
- First posted
- 2024-12-05
- Last updated
- 2024-12-05
Source: ClinicalTrials.gov record NCT06717360. Inclusion in this directory is not an endorsement.